Nerve Growth Factor (NGF) is a key differentiation and maintenance protein for sensory, sympathetic, and central neurons. Information is available about the protein structure of the active beta-subunit and the 7S oligomeric form of the protein, the developmental role of NGF in the nervous system, the structure of its plasma membrane receptor, the cellular dynamics and movement of the receptor subsequent to binding, and some aspects of the signalling required for differentiation of responsive cells. Information about the structure-function relationships of the beta-NGF molecule is essential for understanding such neuronotrophic proteins. The overall goal of this project is to determine structural features of the active beta-NGF subunit that are responsible for interaction with the cellular receptor and resultant intracellular signalling, using recombinant DNA and immunochemical approaches. Molecular engineering.
One aim i s to obtain beta-NGF variants with amino acid replacements in four selected regions of the molecule and correlate these structural changes with biological properties. In the previous grant period biologically active NGF has been successfully expressed in an E. coli system utilizing the cloned moused cDNA. Site specific mutagenesis of critical amino acids will now allow determination of the role of individual residues in biological function. Antagonists and partial agonists of beta-NGF may also be obtained for biological studies. Immunochemistry. Another aim is to determine surface epitopes of the NGF molecule involved in receptor recognition by producing site-specific antibodies directed against synthetic oligopeptides of the NGF protein. Oligopeptides corresponding to particular sequences in the beta-NGF molecule are being synthesized, site specific antibodies toward them will be produced, and the antibodies will be used to ascertain the functional role of surface portions of the beta-NGF molecule. These mutant NGF proteins and site specific antibodies will be studied by neurite outgrowth in rat Pheochromocytoma (PC12) cells and chick dorsal root sensory neurons, in receptor binding and cellular trafficking in PC12 cells, in cellular signalling and gene regulation, in the self-dimerization of beta-NGF, in the formation of the 7S oligomer, and analysis of the conformation of the recombinant protein. The results of these studies will further our knowledge of the fundamental structural requirements for the interaction of NGF with neuronal targets and elucidate molecular and cellular aspects of neuronal differentiation and survival. Novel analogues of NGF will be produced that should be useful in developmental studies. this information will eventually lead to better understanding of neurodevelopmental problems and related diseased such as Alzheimer's and Huntington's diseases.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
5R01NS024380-04
Application #
3408913
Study Section
Neurology C Study Section (NEUC)
Project Start
1987-02-01
Project End
1990-10-31
Budget Start
1990-02-01
Budget End
1990-10-31
Support Year
4
Fiscal Year
1990
Total Cost
Indirect Cost
Name
Case Western Reserve University
Department
Type
Schools of Medicine
DUNS #
077758407
City
Cleveland
State
OH
Country
United States
Zip Code
44106
Mehta, Hrishikesh M; Woo, Sang B; Neet, Kenneth E (2012) Comparison of nerve growth factor receptor binding models using heterodimeric muteins. J Neurosci Res 90:2259-71
Bai, Yujing; Dergham, Pauline; Nedev, Hinyu et al. (2010) Chronic and acute models of retinal neurodegeneration TrkA activity are neuroprotective whereas p75NTR activity is neurotoxic through a paracrine mechanism. J Biol Chem 285:39392-400
Rogers, Mary-Louise; Bailey, Sheree; Matusica, Dusan et al. (2010) ProNGF mediates death of Natural Killer cells through activation of the p75NTR-sortilin complex. J Neuroimmunol 226:93-103
Masoudi, Raheleh; Ioannou, Maria S; Coughlin, Michael D et al. (2009) Biological activity of nerve growth factor precursor is dependent upon relative levels of its receptors. J Biol Chem 284:18424-33
Mahapatra, Sidharth; Mehta, Hrishikesh; Woo, Sang B et al. (2009) Identification of critical residues within the conserved and specificity patches of nerve growth factor leading to survival or differentiation. J Biol Chem 284:33600-13
Boutilier, Jacqueline; Ceni, Claire; Pagdala, Promila C et al. (2008) Proneurotrophins require endocytosis and intracellular proteolysis to induce TrkA activation. J Biol Chem 283:12709-16
Ivanisevic, Ljubica; Zheng, WenHua; Woo, Sang B et al. (2007) TrkA receptor ""hot spots"" for binding of NT-3 as a heterologous ligand. J Biol Chem 282:16754-63
Pagadala, Promila C; Dvorak, Laura A; Neet, Kenneth E (2006) Construction of a mutated pro-nerve growth factor resistant to degradation and suitable for biophysical and cellular utilization. Proc Natl Acad Sci U S A 103:17939-43
Vaghefi, Houman; Neet, Kenneth E (2004) Deacetylation of p53 after nerve growth factor treatment in PC12 cells as a post-translational modification mechanism of neurotrophin-induced tumor suppressor activation. Oncogene 23:8078-87
Vaghefi, Houman; Hughes, Allison L; Neet, Kenneth E (2004) Nerve growth factor withdrawal-mediated apoptosis in naive and differentiated PC12 cells through p53/caspase-3-dependent and -independent pathways. J Biol Chem 279:15604-14

Showing the most recent 10 out of 37 publications